Executives with the innovative late development-stage pharmaceutical startup, Bridge Therapeutics, announced they will be introducing their chronic pain development program at the American Chronic Pain Association (ACPA) Roundtable. The ACPA offers peer support and education in pain management skills to people with chronic pain, along with their families, friends, and healthcare professionals.

Alton Kelley, Director of Business Development for Bridge Therapeutics, said this roundtable will give the chronic pain community an opportunity to learn more about Bridge Therapeutics’ current developments on pain relievers and promoting the ACPA’s efforts in fighting chronic pain.